Editas Cash from 2010 to 2024
| EDIT Stock | USD 5.48 0.16 3.01% |
Cash | First Reported 2013-12-31 | Previous Quarter 82.5 M | Current Value 123.7 M | Quarterly Volatility 95.1 M |
Check Editas Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Editas main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 M, Interest Expense of 3 M or Selling General Administrative of 57.9 M, as well as many exotic indicators such as Price To Sales Ratio of 9.36, Dividend Yield of 0.0 or PTB Ratio of 2.31. Editas financial statements analysis is a perfect complement when working with Editas Medicine Valuation or Volatility modules.
Editas | Cash |
Latest Editas Medicine's Cash Growth Pattern
Below is the plot of the Cash of Editas Medicine over the last few years. Cash refers to the most liquid asset of Editas Medicine, which is listed under current asset account on Editas Medicine balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Editas Medicine customers. The amounts must be unrestricted with restricted cash listed in a different Editas Medicine account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Editas Medicine's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Editas Medicine's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Editas Cash Regression Statistics
| Arithmetic Mean | 108,136,547 | |
| Geometric Mean | 41,059,087 | |
| Coefficient Of Variation | 75.69 | |
| Mean Deviation | 69,601,564 | |
| Median | 139,682,000 | |
| Standard Deviation | 81,853,305 | |
| Sample Variance | 6700T | |
| Range | 236.2M | |
| R-Value | 0.74 | |
| Mean Square Error | 3301.7T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 13,479,791 | |
| Total Sum of Squares | 93799.5T |
Editas Cash History
Other Fundumenentals of Editas Medicine
Editas Medicine Cash component correlations
Click cells to compare fundamentals
About Editas Medicine Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Editas Medicine income statement, its balance sheet, and the statement of cash flows. Editas Medicine investors use historical funamental indicators, such as Editas Medicine's Cash, to determine how well the company is positioned to perform in the future. Although Editas Medicine investors may use each financial statement separately, they are all related. The changes in Editas Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Editas Medicine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Editas Medicine Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Editas Medicine. Please read more on our technical analysis and fundamental analysis pages.
Pair Trading with Editas Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Editas Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will appreciate offsetting losses from the drop in the long position's value.Moving together with Editas Stock
| 0.61 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
| 0.83 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.77 | ELAN | Elanco Animal Health Financial Report 14th of May 2024 | PairCorr |
Moving against Editas Stock
| 0.81 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
| 0.72 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.47 | FLGC | Flora Growth Corp Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Editas Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Editas Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Editas Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Editas Medicine to buy it.
The correlation of Editas Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Editas Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Editas Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Editas Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Editas Medicine Correlation against competitors. For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Editas Stock analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Editas Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Editas Medicine. If investors know Editas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Editas Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.02) | Revenue Per Share 1.028 | Quarterly Revenue Growth 8.187 | Return On Assets (0.21) | Return On Equity (0.43) |
The market value of Editas Medicine is measured differently than its book value, which is the value of Editas that is recorded on the company's balance sheet. Investors also form their own opinion of Editas Medicine's value that differs from its market value or its book value, called intrinsic value, which is Editas Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Editas Medicine's market value can be influenced by many factors that don't directly affect Editas Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Editas Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Editas Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Editas Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.